From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Compound class:
Synthetic organic
Comment: BMS-986458 is an orally bioavailable bifunctional degrader molecule that is designed to target the BCL6 transcription factor in B-cell lymphomas [1]. It promotes CRL4CRBN E3 ubiquitin ligase-dependent dagradation of the BCL6 protein. The chemical structure was disclosed during the 'First Time disclosures' session at the ACS Spring 2025 meeting in San Diego. This matches one of the compounds claimed in patent WO2023212147A1 [2].
|
|
|||||||||||||||||||||||||||||||||||
| Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||